Recent

% | $
Quotes you view appear here for quick access.

Affymax, Inc. Message Board

dblornil 1 post  |  Last Activity: May 25, 2016 5:47 PM Member since: Oct 16, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • dblornil by dblornil May 25, 2016 5:47 PM Flag

    I'm going to buy in...just looking for a pull back, although I don't think i'm going to get it. i understand there is a 45% short interest so i fear this will just keep going up.

    so I've read all of the science posts and it sounds difficult to approve the drug but i'm looking at the non-science view point. when you have no other drug that helps and this one does according to 100s of families that attended the fda meetings plus you can visually see the benefit in the kids and families...well that's pretty solid. I wouldn't want to be the one denying them help. and if the press gets behind this the fda is going to be hard press to explain. no other drug and 3 others have failed...

    also janet woodcock, the director of the Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration (FDA). The center makes sure that safe and effective drugs are available to improve the health of people in the United States. "New drugs—and new uses for older drugs—save lives, reduce suffering, and improve the quality of life for millions of Americans," says Dr. Woodcock. "I am continually challenged to make sure that FDA’s regulatory process remains the world's gold standard for drug approval and safety." the reduce suffering got to me and hoping she really feels that way...

    as I understand she is strongly supportive of the drug and the families that need/want this, and she can overrule the panel. its been done before, rare, but has been done. that's one kicker, the other kicker is she can respond the other way, not to approve. so as you can tell, i'm going for the compassion vote. those with children understand

AFFY
0.0750.0000(0.00%)May 27 2:44 PMEDT